Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Innovation Council · Finished

MICK Translational Microbiome Platform

Coordinator
Sequentia Biotech SL, Spain
Runs
1 September 2022 to 28 February 2025
Status
Finished
EU funding
€2.2m
Total cost
€3.1m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190195702

What the project is doing

In the project's own words, from its summary on CORDIS.

Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and pathologies. The analysis of the microbiome is necessary to detect, assess and monitor it. Nevertheless, microbiome analysis and its application to the clinical field is very complex, expensive, and time-consuming. We created MICK, the first digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice.

MICK automated platform analyses microbiome raw data in real-time, with the highest accuracy and translates it into evidence-based analytics, insights, and practical recommendations. MICK allows customers (clinical centres and diagnostics labs) to scale their service offering to patients without any upfront investment, determining up to 75% cost reduction and faster TAT compared to existing solutions.

Topics

Who is involved

OrganisationCityCountryRole
Sequentia Biotech SLBarcelonaSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI